Release

Today’s Research Reports on Trending Tickers: Sangamo Therapeutics and MEI Pharma

Wall Street retreated from records on Thursday, on news that U.S. President Donald Trump wants to move ahead with his plan to slap tariffs on $200 billion worth additional Chinese imports. Investors will appear to fret if current administration remains aggressive towards its trade policies. The Dow Jones Industrial Average closed 0.53 percent lower to settle at 25,986.92, while the S&P 500 Index dropped 0.44 percent to close at 2,901.13. The Nasdaq Composite Index edged declined 0.26 percent to close at 8,088.36.

RDI Initiates Coverage on:

Sangamo Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=SGMO

MEI Pharma, Inc.
https://rdinvesting.com/news/?ticker=MEIP

Sangamo Therapeutics’ stock jumped 8.04% Thursday, to close the day at $18.15. The stock recorded a trading volume of 4,395,900 shares, which was above its three months average volume of 2,102,776 shares. In the last year, Sangamo Therapeutics’ shares have traded in a range of 11.30 – 27.50. The share price has gained 60.62% from its 52 week low. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $14.84 is below its 200-day moving average of $17.72. Shares of Sangamo Therapeutics have gained roughly 38.65 percent in the past month and are up 10.67 percent year-to-date.

Access RDI’s Sangamo Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=SGMO

On Thursday, shares of MEI Pharma recorded a trading volume of 460,299 shares, which was below the three months average volume of 462,555 shares. The stock ended the day 5.65% higher at $4.49. The share price has fallen 12.65% from its 52 week high with a 52 week trading range of 1.79 – 5.14. The company’s shares are currently trading above their 200-day moving average. The stock’s 50-day moving average of $3.88 is above its 200-day moving average of $3.11. Shares of MEI Pharma have gained roughly 22.34 percent in the past month and are up 113.81 percent year-to-date.

Access RDI’s MEI Pharma, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=MEIP

Our Actionable Research on Sangamo Therapeutics, Inc. (NASDAQ:SGMO) and MEI Pharma, Inc. (NASDAQ:MEIP) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Email:

[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.